GAITHERSBURG, Md. , Jan. 20, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has entered into a license agreement with Pfizer for use of Novavax's Matrix-M ® adjuvant. Under the terms of...
2 Growth Stocks with Explosive Upside and 1 That Underwhelm
GAITHERSBURG, Md. , Jan. 7, 2026 /PRNewswire/ --Â Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44 th Annual J.P. Morgan Healthcare Conference.
Q3 Earnings Outperformers: Novavax (NASDAQ:NVAX) And The Rest Of The Therapeutics Stocks
Novavax (NVAX) Stock Trades Up, Here Is Why
Novavax (NASDAQ:NVAX) Surprises With Q3 CY2025 Sales
GAITHERSBURG, Md. , Nov. 12, 2025 /PRNewswire/ --Â Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference:
GAITHERSBURG, Md. , Nov. 6, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the third quarter ended September 30, 2025.
GAITHERSBURG, Md. , Nov. 4, 2025 /PRNewswire/ --Â Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovidâ„¢ to Sanofi, enabling...